CareLit Fachartikel
CXCR4-Upregulation in Atherosclerotic Plaques is Attenuated by the Anti-Inflammatory and Anti-Fibrotic Drug Pirfenidone
D Weiberg, J Diekmann, A Prasse, HJ Wester, TL Ross, T Welte, T Derlin, FM Bengel · Nuklearmedizin - NuclearMedicine · 2020 · Heft 02
Dokument
1214778
CareLit-ID
Jahr
2020
Publikation
PDF
nein
Metadaten
DOI
ja
zitierfähig
Bibliografische Angaben
Zusammenfassung
CXCR4-Upregulation in Atherosclerotic Plaques is Attenuated by the Anti-Inflammatory and Anti-Fibrotic Drug Pirfenidone
Schlagworte
Cxcr4-Upregulation
Atherosclerotic
Plaques
Attenuated
Anti-Inflammatory
Anti-Fibrotic
Pirfenidone
Nuklearmedizin - NuclearMedicine